REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinil Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sinil Pharmaceutical Co.,Ltd. Profile Updated: January 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sinil Pharmaceutical Co.,Ltd. is engaged in manufacturing, distribution and sale of pharmaceutical products. The company offers medicines for musculoskeletal, gastrointestinal system, circulatory system, respiratory system, and nutrients. Sinil Pharmaceutical Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1977 as Sinil Pharm Ltd.

Headquarters
5-1 Bonpyeong-Ri, Angseong-Myeon, Chungju-Si
Chungju; Chungcheongbuk; Postal Code: 380-862

Contact Details: Purchase the Sinil Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.sinilpharm.com

Basic Information
Total Employees:
Purchase the Sinil Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Sinil Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Sinil Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Sinil Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
December 16, 1977
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
17.8%
Purchase this report to view the information.
8.4%
Purchase this report to view the information.
6.5%
Purchase this report to view the information.
3.9%
Purchase this report to view the information.
1.9%
Subsidiaries
E-bada com
11.1%
Korea Futures & Information
0.3%
Company Performance
Financial values in the chart are available after Sinil Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
10.49%
Total operating revenue
10.74%
Operating profit (EBIT)
5.04%
Net Profit (Loss) for the Period
5.5%
Total assets
7.44%
Total equity
8.75%
Operating Profit Margin (ROS)
-0.83%
Net Profit Margin
-0.65%
Return on Equity (ROE)
-0.21%
Debt to Equity Ratio
-0.07%
Quick Ratio
-0.48%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?